Home -> Law Blog Directory -> Personal Injury Law Blogs -> Philadelphia Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Philadelphia Personal Injury LawyerRaptiva Gets New Labeling
By Jamie Sheller
The psoriasis drug Raptiva will get some new labeling changes, announced the FDA. Raptiva's new label will include a Boxed Warning highlighting the risks of life-threatening infections. Raptiva is administered as an injection to treat moderate to severe plaque psoriasis in adults. It is not approved for children under 18. Some of the infections included in the new Boxed Warning are bacterial sepsis, viral meningitis, invasive fungal disease and progressive multifocal leukoencephalopathy (PML). The FDA's post-market surveillance of Raptiva led to the label changes. Because Raptiva works to suppress the immune system, it can increase the risk of serious infections. Doctors should closely monitor their patients who are using Raptiva and should educate the patients about the signs and symptoms of adverse effects of Raptiva.
Originally posted at InjuryBoard by Jamie Sheller
Full post as published by Philadelphia Personal Injury Lawyer on October 19, 2008 (boomark / email).
Raptiva
3 Patients Dead from Therapy-Related PML
Wrinkle-Fillers
FDA to Review Labeling due to Adverse Event Reports
Transdermal Drug Patches
Risk of Burns Missing From Some Labeling
Dobutamine Hydrochloride Injection
Labeling Errors Prompts Recall of 250 mg/20 ml Injections
FDA
Requests Labeling Change for Singulair, Accolate and Zyflo and Zyflo CR
Food/Supplements
involving food poisoning, food product recalls, false advertising or labeling, vitamin, weight loss and diet supplement issues.

Small Type and Large Loopholes in New Labeling Laws
Paxil and Other Drugs to Get Labeling Change
Striking a Balance: Drug Labeling and the FDA
FDA Orders Labeling Changes for Anemia Drugs
FDA Mulls Changes to Food Allergy Labeling








